Thousands of women whose breast cancer has become resistant to standard treatment could benefit from
It is hoped the new approach will target cancer stem cells that evade conventional drugs and cause the tumour to re-grow
Cancer that has spread and is incurable
Researchers from Manchester University working with drug development company Evgen Pharma
says research presented at the American Association of Cancer Research annual conference today
